Laboratory Corporation of America Holdings (0JSY.L)
USD 231.25
(0.24%)
USD 231.25
(0.24%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 5.95 Billion USD | -5.41% |
| 2022 | 6.29 Billion USD | -0.75% |
| 2021 | 6.34 Billion USD | -6.12% |
| 2020 | 6.75 Billion USD | -4.61% |
| 2019 | 7.08 Billion USD | 16.88% |
| 2018 | 6.05 Billion USD | -10.39% |
| 2017 | 6.76 Billion USD | 15.6% |
| 2016 | 5.84 Billion USD | -8.84% |
| 2015 | 6.41 Billion USD | 111.8% |
| 2014 | 3.02 Billion USD | 1.47% |
| 2013 | 2.98 Billion USD | 12.46% |
| 2012 | 2.65 Billion USD | 19.54% |
| 2011 | 2.22 Billion USD | 235.65% |
| 2010 | 661.7 Million USD | -52.52% |
| 2009 | 1.39 Billion USD | -19.03% |
| 2008 | 1.72 Billion USD | 3.24% |
| 2007 | 1.66 Billion USD | 44.03% |
| 2006 | 1.15 Billion USD | 0.72% |
| 2005 | 1.14 Billion USD | 28.78% |
| 2004 | 892.3 Million USD | 0.92% |
| 2003 | 884.2 Million USD | 69.42% |
| 2002 | 521.9 Million USD | 2.55% |
| 2001 | 508.9 Million USD | 4.78% |
| 2000 | 485.7 Million USD | -15.94% |
| 1999 | 577.8 Million USD | -10.83% |
| 1998 | 648 Million USD | -6.03% |
| 1997 | 689.6 Million USD | -46.14% |
| 1996 | 1.28 Billion USD | 26.65% |
| 1995 | 1.01 Billion USD | 67.7% |
| 1994 | 602.8 Million USD | 87.91% |
| 1993 | 320.8 Million USD | 120.48% |
| 1992 | 145.5 Million USD | 0.0% |
| 1991 | - USD | -100.0% |
| 1990 | 22 Million USD | 0.0% |
| 1989 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 6.75 Billion USD | 29.19% |
| 2024 Q1 | 5.97 Billion USD | 0.11% |
| 2023 Q3 | 5.95 Billion USD | -5.94% |
| 2023 Q1 | 6.21 Billion USD | -1.29% |
| 2023 FY | 5.95 Billion USD | -5.41% |
| 2023 Q4 | 5.96 Billion USD | 0.24% |
| 2023 Q2 | 6.32 Billion USD | 1.93% |
| 2022 Q4 | 6.29 Billion USD | -0.06% |
| 2022 FY | 6.29 Billion USD | -0.75% |
| 2022 Q2 | 6.27 Billion USD | -0.71% |
| 2022 Q1 | 6.31 Billion USD | 0.38% |
| 2022 Q3 | 6.29 Billion USD | 0.38% |
| 2021 Q4 | 6.29 Billion USD | -0.8% |
| 2021 FY | 6.34 Billion USD | -6.12% |
| 2021 Q3 | 6.34 Billion USD | 0.11% |
| 2021 Q2 | 6.33 Billion USD | -0.35% |
| 2021 Q1 | 6.35 Billion USD | -0.04% |
| 2020 Q3 | 6.75 Billion USD | 1.09% |
| 2020 Q2 | 6.68 Billion USD | -6.05% |
| 2020 Q4 | 6.36 Billion USD | -5.86% |
| 2020 Q1 | 7.11 Billion USD | -0.05% |
| 2020 FY | 6.75 Billion USD | -4.61% |
| 2019 Q3 | 7.08 Billion USD | -4.65% |
| 2019 Q4 | 7.11 Billion USD | 0.49% |
| 2019 Q2 | 7.42 Billion USD | -2.0% |
| 2019 FY | 7.08 Billion USD | 16.88% |
| 2019 Q1 | 7.57 Billion USD | 11.15% |
| 2018 Q3 | 6.05 Billion USD | -6.23% |
| 2018 Q1 | 6.45 Billion USD | -4.72% |
| 2018 FY | 6.05 Billion USD | -10.39% |
| 2018 Q4 | 6.81 Billion USD | 12.54% |
| 2018 Q2 | 6.46 Billion USD | 0.08% |
| 2017 Q3 | 6.76 Billion USD | -6.32% |
| 2017 Q4 | 6.77 Billion USD | 0.22% |
| 2017 Q2 | 7.21 Billion USD | 17.8% |
| 2017 Q1 | 6.12 Billion USD | 3.49% |
| 2017 FY | 6.76 Billion USD | 15.6% |
| 2016 Q2 | 6.17 Billion USD | 1.92% |
| 2016 Q3 | 5.84 Billion USD | -5.22% |
| 2016 Q4 | 5.92 Billion USD | 1.22% |
| 2016 FY | 5.84 Billion USD | -8.84% |
| 2016 Q1 | 6.05 Billion USD | -5.32% |
| 2015 Q3 | 6.41 Billion USD | -3.95% |
| 2015 Q2 | 6.68 Billion USD | -1.56% |
| 2015 Q1 | 6.78 Billion USD | -2.29% |
| 2015 FY | 6.41 Billion USD | 111.8% |
| 2015 Q4 | 6.39 Billion USD | -0.34% |
| 2014 Q4 | 6.94 Billion USD | 129.27% |
| 2014 FY | 3.02 Billion USD | 1.47% |
| 2014 Q3 | 3.02 Billion USD | 0.5% |
| 2014 Q1 | 3 Billion USD | 0.56% |
| 2014 Q2 | 3.01 Billion USD | 0.24% |
| 2013 FY | 2.98 Billion USD | 12.46% |
| 2013 Q3 | 2.98 Billion USD | 12.08% |
| 2013 Q2 | 2.66 Billion USD | 6.14% |
| 2013 Q4 | 2.99 Billion USD | 0.16% |
| 2013 Q1 | 2.5 Billion USD | 8.06% |
| 2012 FY | 2.65 Billion USD | 19.54% |
| 2012 Q4 | 2.32 Billion USD | -12.52% |
| 2012 Q1 | 2.1 Billion USD | -0.56% |
| 2012 Q2 | 2.66 Billion USD | 26.09% |
| 2012 Q3 | 2.65 Billion USD | -0.19% |
| 2011 Q4 | 2.12 Billion USD | -4.48% |
| 2011 FY | 2.22 Billion USD | 235.65% |
| 2011 Q2 | 1.98 Billion USD | -0.98% |
| 2011 Q1 | 2 Billion USD | -9.1% |
| 2011 Q3 | 2.22 Billion USD | 11.97% |
| 2010 Q1 | 1.32 Billion USD | -0.41% |
| 2010 Q2 | 1.34 Billion USD | 1.75% |
| 2010 Q4 | 2.2 Billion USD | 0.71% |
| 2010 Q3 | 2.18 Billion USD | 62.69% |
| 2010 FY | 661.7 Million USD | -52.52% |
| 2009 Q3 | 1.39 Billion USD | -0.44% |
| 2009 Q1 | 1.41 Billion USD | -17.52% |
| 2009 Q2 | 1.4 Billion USD | -0.79% |
| 2009 FY | 1.39 Billion USD | -19.03% |
| 2009 Q4 | 1.32 Billion USD | -4.8% |
| 2008 Q3 | 1.72 Billion USD | -0.32% |
| 2008 FY | 1.72 Billion USD | 3.24% |
| 2008 Q1 | 1.65 Billion USD | -1.4% |
| 2008 Q2 | 1.72 Billion USD | 4.05% |
| 2008 Q4 | 1.71 Billion USD | -0.57% |
| 2007 Q4 | 1.68 Billion USD | 0.98% |
| 2007 Q3 | 1.66 Billion USD | 31.84% |
| 2007 Q1 | 1.16 Billion USD | -6.29% |
| 2007 FY | 1.66 Billion USD | 44.03% |
| 2007 Q2 | 1.26 Billion USD | 8.82% |
| 2006 Q3 | 1.15 Billion USD | 0.14% |
| 2006 Q4 | 1.23 Billion USD | 7.13% |
| 2006 FY | 1.15 Billion USD | 0.72% |
| 2006 Q1 | 1.15 Billion USD | 0.14% |
| 2006 Q2 | 1.15 Billion USD | 0.23% |
| 2005 Q4 | 1.15 Billion USD | 0.22% |
| 2005 FY | 1.14 Billion USD | 28.78% |
| 2005 Q1 | 954.4 Million USD | 6.65% |
| 2005 Q2 | 899.5 Million USD | -5.75% |
| 2005 Q3 | 1.14 Billion USD | 27.75% |
| 2004 Q2 | 890.1 Million USD | 0.23% |
| 2004 Q1 | 888.1 Million USD | 0.23% |
| 2004 Q4 | 894.9 Million USD | 0.29% |
| 2004 FY | 892.3 Million USD | 0.92% |
| 2004 Q3 | 892.3 Million USD | 0.25% |
| 2003 Q1 | 93 Million USD | -90.78% |
| 2003 FY | 884.2 Million USD | 69.42% |
| 2003 Q4 | 886.1 Million USD | 0.21% |
| 2003 Q3 | 884.2 Million USD | -2.51% |
| 2003 Q2 | 907 Million USD | 875.27% |
| 2002 Q1 | 513.3 Million USD | 0.43% |
| 2002 Q2 | 640.3 Million USD | 24.74% |
| 2002 Q3 | 521.9 Million USD | -18.49% |
| 2002 Q4 | 1 Billion USD | 93.24% |
| 2002 FY | 521.9 Million USD | 2.55% |
| 2001 FY | 508.9 Million USD | 4.78% |
| 2001 Q2 | 443.5 Million USD | -5.46% |
| 2001 Q1 | 469.1 Million USD | 3.69% |
| 2001 Q3 | 508.9 Million USD | 14.75% |
| 2001 Q4 | 511.1 Million USD | 0.43% |
| 2000 FY | 485.7 Million USD | -15.94% |
| 2000 Q1 | 530 Million USD | -3.41% |
| 2000 Q4 | 452.4 Million USD | -6.86% |
| 2000 Q3 | 485.7 Million USD | -4.33% |
| 2000 Q2 | 507.7 Million USD | -4.21% |
| 1999 Q2 | 589 Million USD | -4.92% |
| 1999 Q4 | 548.7 Million USD | -5.04% |
| 1999 Q3 | 577.8 Million USD | -1.9% |
| 1999 Q1 | 619.5 Million USD | -2.59% |
| 1999 FY | 577.8 Million USD | -10.83% |
| 1998 Q4 | 636 Million USD | -1.85% |
| 1998 Q3 | 648 Million USD | 0.06% |
| 1998 Q1 | 648.7 Million USD | -1.58% |
| 1998 Q2 | 647.6 Million USD | -0.17% |
| 1998 FY | 648 Million USD | -6.03% |
| 1997 Q2 | 713.5 Million USD | -2.07% |
| 1997 Q3 | 689.6 Million USD | -3.35% |
| 1997 Q4 | 659.1 Million USD | -4.42% |
| 1997 Q1 | 728.6 Million USD | -42.84% |
| 1997 FY | 689.6 Million USD | -46.14% |
| 1996 FY | 1.28 Billion USD | 26.65% |
| 1996 Q1 | 1.08 Billion USD | 7.05% |
| 1996 Q2 | 1.1 Billion USD | 1.81% |
| 1996 Q3 | 1.28 Billion USD | 16.17% |
| 1996 Q4 | 1.27 Billion USD | -0.45% |
| 1995 Q3 | 1.01 Billion USD | -1.64% |
| 1995 Q4 | 1.01 Billion USD | 0.03% |
| 1995 Q1 | 809.9 Million USD | 27.52% |
| 1995 FY | 1.01 Billion USD | 67.7% |
| 1995 Q2 | 1.02 Billion USD | 26.9% |
| 1994 Q3 | 602.8 Million USD | -5.03% |
| 1994 FY | 602.8 Million USD | 87.91% |
| 1994 Q1 | 592.8 Million USD | 69.08% |
| 1994 Q2 | 634.7 Million USD | 7.07% |
| 1994 Q4 | 635.1 Million USD | 5.36% |
| 1993 Q4 | 350.6 Million USD | 9.29% |
| 1993 Q3 | 320.8 Million USD | 35.93% |
| 1993 Q2 | 236 Million USD | 14.06% |
| 1993 Q1 | 206.9 Million USD | 44.08% |
| 1993 FY | 320.8 Million USD | 120.48% |
| 1992 Q1 | 85 Million USD | -15.0% |
| 1992 Q4 | 143.6 Million USD | -1.31% |
| 1992 Q2 | 85 Million USD | 0.0% |
| 1992 FY | 145.5 Million USD | 0.0% |
| 1992 Q3 | 145.5 Million USD | 71.18% |
| 1991 Q4 | 100 Million USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| 1991 FY | - USD | -100.0% |
| 1991 Q3 | - USD | 0.0% |
| 1991 Q1 | - USD | 0.0% |
| 1990 Q4 | - USD | -100.0% |
| 1990 Q2 | - USD | 0.0% |
| 1990 FY | 22 Million USD | 0.0% |
| 1990 Q1 | - USD | 0.0% |
| 1990 Q3 | 22 Million USD | 0.0% |
| 1989 Q4 | - USD | 0.0% |
| 1989 Q1 | - USD | 0.0% |
| 1989 Q3 | - USD | 0.0% |
| 1989 Q2 | - USD | 0.0% |
| 1989 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Phreesia, Inc. | 11.98 Million USD | -49588.726% |
| Accuray Incorporated | 172.15 Million USD | -3358.607% |
| Align Technology, Inc. | 96.96 Million USD | -6040.376% |
| Elevance Health Inc. | 25.12 Billion USD | 76.297% |
| AxoGen, Inc. | 69.29 Million USD | -8492.911% |
| Boston Scientific Corporation | 9.09 Billion USD | 34.548% |
| CVS Health Corporation | 79.38 Billion USD | 92.5% |
| Cardinal Health, Inc. | 5.6 Billion USD | -6.154% |
| Centene Corporation | 17.69 Billion USD | 66.359% |
| DaVita Inc. | 11.11 Billion USD | 46.438% |
| HCA Healthcare, Inc. | 41.85 Billion USD | 85.776% |
| Hologic, Inc. | 2.53 Billion USD | -134.917% |
| Humana Inc. | 10.21 Billion USD | 41.7% |
| IDEXX Laboratories, Inc. | 947.88 Million USD | -528.16% |
| Masimo Corporation | 970 Million USD | -513.835% |
| McKesson Corporation | 5.47 Billion USD | -8.812% |
| Patterson Companies, Inc. | 762.94 Million USD | -680.428% |
| Quest Diagnostics Incorporated | 5.36 Billion USD | -10.9% |
| ResMed Inc. | 873.93 Million USD | -581.309% |
| Henry Schein, Inc. | 2.74 Billion USD | -117.227% |
| Teladoc Health, Inc. | 1.59 Billion USD | -273.942% |
| Universal Health Services, Inc. | 5.36 Billion USD | -10.949% |
| Veeva Systems Inc. | 55.77 Million USD | -10575.392% |
| Baxter International Inc. | 14.36 Billion USD | 58.548% |
| Becton, Dickinson and Company | 15.87 Billion USD | 62.503% |
| Intuitive Surgical, Inc. | 89.8 Million USD | -6530.512% |
| Danaher Corporation | 19.35 Billion USD | 69.238% |
| Stryker Corporation | 12.99 Billion USD | 54.181% |
| Medtronic plc | 24.96 Billion USD | 76.148% |